DE602005010548D1 - Verbessertes verfahren zur diagnose des akuten koronarsyndroms - Google Patents

Verbessertes verfahren zur diagnose des akuten koronarsyndroms

Info

Publication number
DE602005010548D1
DE602005010548D1 DE602005010548T DE602005010548T DE602005010548D1 DE 602005010548 D1 DE602005010548 D1 DE 602005010548D1 DE 602005010548 T DE602005010548 T DE 602005010548T DE 602005010548 T DE602005010548 T DE 602005010548T DE 602005010548 D1 DE602005010548 D1 DE 602005010548D1
Authority
DE
Germany
Prior art keywords
papp
free
prombp
complexed
acute coronary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005010548T
Other languages
English (en)
Inventor
Qiu-Ping Qin
Kim Pettersson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Turku
Original Assignee
University of Turku
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34826080&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602005010548(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by University of Turku filed Critical University of Turku
Publication of DE602005010548D1 publication Critical patent/DE602005010548D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/471—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Detection And Correction Of Errors (AREA)
  • Detection And Prevention Of Errors In Transmission (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE602005010548T 2004-01-28 2005-01-19 Verbessertes verfahren zur diagnose des akuten koronarsyndroms Active DE602005010548D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53943104P 2004-01-28 2004-01-28
PCT/FI2005/000036 WO2005073727A1 (en) 2004-01-28 2005-01-19 Improved method for diagnosing acute coronary syndrome

Publications (1)

Publication Number Publication Date
DE602005010548D1 true DE602005010548D1 (de) 2008-12-04

Family

ID=34826080

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005010548T Active DE602005010548D1 (de) 2004-01-28 2005-01-19 Verbessertes verfahren zur diagnose des akuten koronarsyndroms

Country Status (9)

Country Link
US (3) US7824876B2 (de)
EP (1) EP1709448B1 (de)
JP (1) JP4903585B2 (de)
CN (1) CN1934449A (de)
AT (1) ATE412181T1 (de)
CA (1) CA2549066C (de)
DE (1) DE602005010548D1 (de)
ES (1) ES2314624T3 (de)
WO (1) WO2005073727A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1709448B1 (de) * 2004-01-28 2008-10-22 Turun Yliopisto Verbessertes verfahren zur diagnose des akuten koronarsyndroms
EP2309265B1 (de) * 2008-07-31 2013-07-17 Nitto Boseki CO., LTD. Verfahren zur untersuchung eines komplexes und darin zu verwendendes kit
FI20095733A0 (fi) 2009-06-29 2009-06-29 Hytest Oy IGFBP-4-fragmenttien määrittäminen diagnostisena menetelmänä
WO2022125710A1 (en) 2020-12-09 2022-06-16 GHP Solutions, LLC Methods of detecting papp-a and related methods for gestational age assessment
CN113075406A (zh) * 2021-04-15 2021-07-06 江苏优尼泰克生物科技有限公司 用于妊娠相关性血浆蛋白a检测的组合物和磁微球电化学发光免疫检测试剂盒与检测方法
CN116042586A (zh) * 2022-12-23 2023-05-02 北京大学第三医院（北京大学第三临床医学院） 一种妊娠血浆papp-a复合物蛋白、其制备方法及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1206354B (it) * 1977-03-10 1989-04-21 Lepetit Spa Corredo da usarsi per la determinazione degli ormoni liberi nei fluidi biologici
US4366143A (en) * 1979-09-24 1982-12-28 Amersham International Public Limited Company Assay for the free portion of substances in biological fluids
IL121659A (en) * 1996-10-25 2000-07-16 Bayer Ag Method for determining CPSA in a blood sample
JPH10150999A (ja) * 1996-11-22 1998-06-09 Eiken Chem Co Ltd ヒト前立腺特異抗原−α１−アンチキモトリプシン複合体に対するモノクローナル抗体及びそれを用いたヒト前立腺特異抗原−α１−アンチキモトリプシン複合体の免疫学的検出法
JP4437211B2 (ja) * 1999-03-12 2010-03-24 アークレイ株式会社 免疫クロマトグラフィーを用いた測定方法およびそれに用いる検体分析用具
US7115382B1 (en) * 1999-03-15 2006-10-03 Mayo Foundation For Medical Education And Research Method for detecting IGFBP-4 protease without detecting IGFBP-4 protease/proMBP Complex
AU783035B2 (en) * 1999-03-15 2005-09-15 Como Holding Aps Insulin-like growth factor binding protein-4 protease
FR2796952B1 (fr) * 1999-07-30 2003-08-15 Centre Nat Rech Scient Nouvelles applications de peptides issus du domaine cytoplasmique du precurseur de la proteine amyloide
AU2002210403A1 (en) * 2000-10-20 2002-04-29 Como Biotech Aps Pregnancy-associated plasma protein-a2 (papp-a2)
US6500630B2 (en) 2001-01-12 2002-12-31 Mayo Foundation For Medical Education And Research Marker for inflammatory conditions
CA2330894A1 (en) * 2001-01-12 2002-07-12 Universite De Sherbrooke Optically aligned and network-stabilized ferroelectric liquid crystals using azobenzene-containing diacrylate monomers
EP1709448B1 (de) * 2004-01-28 2008-10-22 Turun Yliopisto Verbessertes verfahren zur diagnose des akuten koronarsyndroms

Also Published As

Publication number Publication date
WO2005073727A1 (en) 2005-08-11
ATE412181T1 (de) 2008-11-15
JP4903585B2 (ja) 2012-03-28
US7824876B2 (en) 2010-11-02
JP2007519913A (ja) 2007-07-19
CN1934449A (zh) 2007-03-21
CA2549066A1 (en) 2005-08-11
EP1709448B1 (de) 2008-10-22
US20110014631A1 (en) 2011-01-20
EP1709448A1 (de) 2006-10-11
CA2549066C (en) 2012-11-13
US20120264139A1 (en) 2012-10-18
US20070111254A1 (en) 2007-05-17
ES2314624T3 (es) 2009-03-16

Similar Documents

Publication Publication Date Title
DK1889059T3 (da) Fremgangsmåde til forbedret immunoassay
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
DE602006021777D1 (de) Diagnoseverfahren für präeklampsie
WO2003043487A3 (en) Method of using a non-antibody protein to detect and measure an analyte
ATE536553T1 (de) Verfahren zum nachweis grösserer ungünstiger kardiovaskulärer und zerebrovaskulärer ereignisse
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
DE60025347D1 (de) Methoden zur vohersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-tests
DE602005010548D1 (de) Verbessertes verfahren zur diagnose des akuten koronarsyndroms
ATE469351T1 (de) Turbidimetrischer immunoassay zur beurteilung von humanem cystatin c
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
EP1930445A4 (de) Kit und verfahren zum nachweis von urothelkarzinom
WO2006092729A3 (en) Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals
PL1977244T3 (pl) Rozróżnianie bakteryjnego i wirusowego zapalenia opon mózgowych
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
ATE314648T1 (de) Diagnostisches verfahren für asthma
CY1109461T1 (el) Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου
ATE509270T1 (de) Aus blutplättchen gewonnene mikropartikel als neue diagnosemarker für eine herz-kreislauf- erkrankung
EP1636587A4 (de) Einen für menschliches protoonkogenes protein spezifischen antikörper enthaltender diagnostischer kit für leberzirrhose
GB2456690A (en) A method for quantitative detection of diabetes related immunological markers
BRPI0415562A (pt) reagente para avaliação diagnóstica e/ou prognóstica de carcinoma, métodos para determinação de p-lap que é um fator prognóstico em carcinoma, e para avaliação prognóstica de carcinoma, e, kit de imunoensaio para determinação da quantidade de p-lap presente em tecidos de carcinoma
ATE393393T1 (de) Verwendung des proteins spee als marker für brustkrebs
AR055411A1 (es) Metodo para diagnosticar la hipertension.
CA2530479A1 (en) Use of protein proteasome activator subunit 3 (pse3) as a marker for colorectal cancer
GB0501564D0 (en) Test for prion disease
JP2005249567A5 (de)

Legal Events

Date Code Title Description
8363 Opposition against the patent